7.35 USD
▲+0.06+0.82%
盘后 7.24 0.00%
2026-09-10
市值
$2.73B
市盈率
—
EPS
-2.14
股息率
—
52 周区间
3.27 – 7.45
成交量
9.59M
Beta
1.55
目标价
8.12
52W 低 3.2752W 高 7.45
价格走势
公司简介
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments. The company develops rapid-acting and durable therapies for conditions with limited treatment options. Its pipeline includes BPL-003 (mebufotenin benzoate), an intranasal formulation in Phase 2 and 3 clinical studies for treatment-resistant depression and alcohol use disorder; ELE-101, a serotonergic psychedelic for major depressive disorder; and RL-007, an orally bioavailable pro-cognitive neuro...